Ferroptosis in Cancer Therapy: Mechanisms, Small Molecule Inducers, and Novel Approaches

References

• Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12–49. doi:10.3322/caac.21820
   PubMed Web of Science ®Google Scholar
• Wu Y, Li Y, Gao Y, et al. Immunotherapies of acute myeloid leukemia: rationale, clinical evidence and perspective. Biomed Pharmacother. 2024;171:116132. doi:10.1016/j.biopha.2024.116132
   PubMed Web of Science ®Google Scholar
• Murayama T, Nakayama J, Jiang X, et al. Targeting DHX9 triggers tumor-intrinsic interferon response and replication stress in small cell lung cancer. Cancer Discov. 2024;14(3):468–491. doi:10.1158/2159-8290.Cd-23-0486
   PubMed Web of Science ®Google Scholar
• Xu B, Sun H, Liu S, et al. IFI35 limits antitumor immunity in triple-negative breast cancer via CCL2 secretion. Oncogene. 2024;43(10):693–702. doi:10.1038/s41388-023-02934-w
   PubMed Web of Science ®Google Scholar
• Shishido SN, Lin E, Nissen N, et al. Cancer-related cells and oncosomes in the liquid biopsy of pancreatic cancer patients undergoing surgery. NPJ Precis Oncol. 2024;8(1):36. doi:10.1038/s41698-024-00521-0
   PubMed Web of Science ®Google Scholar
• Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–1072. doi:10.1016/j.cell.2012.03.042
   PubMed Web of Science ®Google Scholar
• Jiang X, Peng Q, Peng M, et al. Cellular metabolism: a key player in cancer ferroptosis. Cancer Commun. 2024;44(2):185–204. doi:10.1002/cac2.12519
   Web of Science ®Google Scholar
• Zhao X, Li X, Xu Y. Ferroptosis: a dual-edged sword in tumour growth. Front Pharmacol. 2023;14:1330910. doi:10.3389/fphar.2023.1330910
   PubMed Web of Science ®Google Scholar
• Yang Z, Wei X, Ji C, et al. OGT/HIF-2α axis promotes the progression of clear cell renal cell carcinoma and regulates its sensitivity to ferroptosis. iScience. 2023;26(11):108148. doi:10.1016/j.isci.2023.108148
   PubMed Web of Science ®Google Scholar
• Tang R, Wu Z, Rong Z, et al.. Ferroptosis-related lncRNA pairs to predict the clinical outcome and molecular characteristics of pancreatic ductal adenocarcinoma. Brief Bioinform. 2022;23(1). doi:10.1093/bib/bbab388
   Web of Science ®Google Scholar
• Li J, He D, Li S, Xiao J, Zhu Z. Ferroptosis: the emerging player in remodeling triple-negative breast cancer. Front Immunol. 2023;14:1284057. doi:10.3389/fimmu.2023.1284057
   PubMed Web of Science ®Google Scholar
• Mojarad-Jabali S, Mahdinloo S, Farshbaf M, et al. Transferrin receptor-mediated liposomal drug delivery: recent trends in targeted therapy of cancer. Expert Opin Drug Deliv. 2022;19(6):685–705. doi:10.1080/17425247.2022.2083106
   PubMed Web of Science ®Google Scholar
• Lee J, Roh JL. Epithelial-mesenchymal plasticity: implications for ferroptosis vulnerability and cancer therapy. Crit Rev Oncol Hematol. 2023;185:103964. doi:10.1016/j.critrevonc.2023.103964
   PubMed Web of Science ®Google Scholar
• Bae C, Hernández Millares R, Ryu S, et al. Synergistic effect of ferroptosis-inducing nanoparticles and X-ray irradiation combination therapy. Small. 2024;20:e2310873. doi:10.1002/smll.202310873
   PubMed Web of Science ®Google Scholar
• Shi TM, Chen XF, Ti H. Ferroptosis-based therapeutic strategies toward precision medicine for cancer. J Med Chem. 2024;67(4):2238–2263. doi:10.1021/acs.jmedchem.3c01749
   PubMed Web of Science ®Google Scholar
• Zhang DD. Ironing out the details of ferroptosis. Nat Cell Biol. 2024. doi:10.1038/s41556-024-01361-7
   Web of Science ®Google Scholar
• Hinokuma H, Kanamori Y, Ikeda K, et al. Distinct functions between ferrous and ferric iron in lung cancer cell growth. Cancer Sci. 2023;114(11):4355–4364. doi:10.1111/cas.15949
   PubMed Web of Science ®Google Scholar
• Hong X, Roh W, Sullivan RJ, et al. The lipogenic regulator SREBP2 induces transferrin in circulating melanoma cells and suppresses ferroptosis. Cancer Discov. 2021;11(3):678–695. doi:10.1158/2159-8290.Cd-19-1500
   PubMed Web of Science ®Google Scholar
• Han Y, Fu L, Kong Y, Jiang C, Huang L, Zhang H. STEAP3 affects ovarian cancer progression by regulating ferroptosis through the p53/SLC7A11 pathway. Mediators Inflamm. 2024;2024:4048527. doi:10.1155/2024/4048527
   PubMed Web of Science ®Google Scholar
• Aron AT, Loehr MO, Bogena J, Chang CJ. An endoperoxide reactivity-based FRET probe for ratiometric fluorescence imaging of labile iron pools in living cells. J Am Chem Soc. 2016;138(43):14338–14346. doi:10.1021/jacs.6b08016
   PubMed Web of Science ®Google Scholar
• Kirbas Cilingir E, Besbinar O, Giro L, et al. Small warriors of nature: novel red emissive chlorophyllin carbon dots harnessing Fenton-fueled ferroptosis for in vitro and in vivo cancer treatment. Small. 2024;20:e2309283. doi:10.1002/smll.202309283
   PubMed Web of Science ®Google Scholar
• Wang X, He M, Zhao Y, et al. Bimetallic PtPd atomic clusters as apoptosis/ferroptosis inducers for antineoplastic therapy through heterogeneous catalytic processes. ACS Nano. 2024. doi:10.1021/acsnano.3c11610
   Web of Science ®Google Scholar
• Wang Y, Ding H, Zheng Y, et al. Alleviated NCOA4-mediated ferritinophagy protected RA FLSs from ferroptosis in lipopolysaccharide-induced inflammation under hypoxia. Inflamm Res. 2024;73(3):363–379. doi:10.1007/s00011-023-01842-9
   PubMed Web of Science ®Google Scholar
• Ye L, Jin F, Kumar SK, Dai Y. The mechanisms and therapeutic targets of ferroptosis in cancer. Expert Opin Ther Targets. 2021;25(11):965–986. doi:10.1080/14728222.2021.2011206
   PubMed Web of Science ®Google Scholar
• Ye L, Wen X, Qin J, et al. Metabolism-regulated ferroptosis in cancer progression and therapy. Cell Death Dis. 2024;15(3):196. doi:10.1038/s41419-024-06584-y
   PubMed Web of Science ®Google Scholar
• Li X, Meng F, Wang H, et al. Iron accumulation and lipid peroxidation: implication of ferroptosis in hepatocellular carcinoma. Front Endocrinol (Lausanne). 2023;14:1319969. doi:10.3389/fendo.2023.1319969
   PubMed Web of Science ®Google Scholar
• Qiu B, Zandkarimi F, Bezjian CT, et al. Phospholipids with two polyunsaturated fatty acyl tails promote ferroptosis. Cell. 2024;187(5):1177–1190.e18. doi:10.1016/j.cell.2024.01.030
   PubMed Web of Science ®Google Scholar
• Samovich SN, Mikulska-Ruminska K, Dar HH, et al. Strikingly high activity of 15-Lipoxygenase towards di-polyunsaturated arachidonoyl/adrenoyl-phosphatidylethanolamines generates peroxidation signals of ferroptotic cell death. Angew Chem Int Ed Engl. 2024;63(9):e202314710. doi:10.1002/anie.202314710
   PubMed Web of Science ®Google Scholar
• Bai XY, Liu XL, Deng ZZ, et al. Ferroptosis is a new therapeutic target for spinal cord injury. Front Neurosci. 2023;17:1136143. doi:10.3389/fnins.2023.1136143
   PubMed Web of Science ®Google Scholar
• Fang X, Ardehali H, Min J, Wang F. The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nat Rev Cardiol. 2023;20(1):7–23. doi:10.1038/s41569-022-00735-4
   PubMed Web of Science ®Google Scholar
• Huang Y, Sarkhel S, Roy A, Mohan A. Interrelationship of lipid aldehydes (MDA, 4-HNE, and 4-ONE) mediated protein oxidation in muscle foods. Crit Rev Food Sci Nutr. 2023;1–17. doi:10.1080/10408398.2023.2245029
   Web of Science ®Google Scholar
• Zou Y, Li H, Graham ET, et al. Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis. Nat Chem Biol. 2020;16(3):302–309. doi:10.1038/s41589-020-0472-6
   PubMed Web of Science ®Google Scholar
• Zheng X, Zhang C. The regulation of ferroptosis by noncoding RNAs. Int J Mol Sci. 2023;24:17.
   Web of Science ®Google Scholar
• Liu L, Ye Y, Lin R, et al. Ferroptosis: a promising candidate for exosome-mediated regulation in different diseases. Cell Commun Signal. 2024;22(1):6. doi:10.1186/s12964-023-01369-w
   PubMed Web of Science ®Google Scholar
• Lara O, Janssen P, Mambretti M, et al. Compartmentalized role of xCT in supporting pancreatic tumor growth, inflammation and mood disturbance in mice. Brain Behav Immun. 2024;118:275–286. doi:10.1016/j.bbi.2024.03.001
   PubMed Web of Science ®Google Scholar
• Kang YP, Mockabee-Macias A, Jiang C, et al. Non-canonical glutamate-cysteine ligase activity protects against ferroptosis. Cell Metab. 2021;33(1):174–189.e7. doi:10.1016/j.cmet.2020.12.007
   PubMed Web of Science ®Google Scholar
• Zhang H, Pan J, Huang S, et al. Hydrogen sulfide protects cardiomyocytes from doxorubicin-induced ferroptosis through the SLC7A11/GSH/GPx4 pathway by Keap1 S-sulfhydration and Nrf2 activation. Redox Biol. 2024;70:103066. doi:10.1016/j.redox.2024.103066
   PubMed Web of Science ®Google Scholar
• Zhang XD, Liu ZY, Wang MS, et al. Mechanisms and regulations of ferroptosis. Front Immunol. 2023;14:1269451. doi:10.3389/fimmu.2023.1269451
   PubMedGoogle Scholar
• Alborzinia H, Chen Z, Yildiz U, et al. LRP8-mediated selenocysteine uptake is a targetable vulnerability in MYCN-amplified neuroblastoma. EMBO Mol Med. 2023;15(8):e18014. doi:10.15252/emmm.202318014
   PubMed Web of Science ®Google Scholar
• Miao H, Meng H, Zhang Y, Chen T, Zhang L, Cheng W. FSP1 inhibition enhances olaparib sensitivity in BRCA-proficient ovarian cancer patients via a nonferroptosis mechanism. Cell Death Differ. 2024;31:497–510. doi:10.1038/s41418-024-01263-z
   PubMed Web of Science ®Google Scholar
• Fišar Z, Hroudová J. CoQ(10) and Mitochondrial dysfunction in alzheimer’s disease. Antioxidants (Basel). 2024;13:2.
   Google Scholar
• Huo J, Xu Z, Hosoe K, et al. Coenzyme Q10 prevents senescence and dysfunction caused by oxidative stress in vascular endothelial cells. Oxid Med Cell Longev. 2018;2018:3181759. doi:10.1155/2018/3181759
   PubMed Web of Science ®Google Scholar
• Bersuker K, Hendricks JM, Li Z, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575:688–692. doi:10.1038/s41586-019-1705-2
   PubMed Web of Science ®Google Scholar
• Díaz M, Valdés-Baizabal C, de Pablo DP, Marin R. Age-dependent changes in Nrf2/Keap1 and target antioxidant protein expression correlate to lipoxidative adducts, and are modulated by dietary N-3 LCPUFA in the hippocampus of mice. Antioxidants (Basel). 2024;13:2.
   Google Scholar
• Song Y, Qu Y, Mao C, Zhang R, Jiang D, Sun X. Post-translational modifications of Keap1: the state of the art. Front Cell Dev Biol. 2023;11:1332049. doi:10.3389/fcell.2023.1332049
   PubMed Web of Science ®Google Scholar
• Gong Z, Xue L, Li H, et al. Targeting Nrf2 to treat thyroid cancer. Biomed Pharmacother. 2024;173:116324. doi:10.1016/j.biopha.2024.116324
   PubMed Web of Science ®Google Scholar
• Li B, Nasser MI, Masood M, et al. Efficiency of traditional Chinese medicine targeting the Nrf2/HO-1 signaling pathway. Biomed Pharmacother. 2020;126:110074. doi:10.1016/j.biopha.2020.110074
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang L, Yao G, Zhao H, Wu S. NRF2 is essential for iron-overload stimulated osteoclast differentiation through regulation of redox and iron homeostasis. Cell Biol Toxicol. 2023;39(6):3305–3321. doi:10.1007/s10565-023-09834-5
   PubMed Web of Science ®Google Scholar
• Jiang X, Gao H, Cao Y, et al. SiNPs induce ferroptosis in HUVECs through p38 inhibiting NrF2 pathway. Front Public Health. 2023;11:1024130. doi:10.3389/fpubh.2023.1024130
   PubMed Web of Science ®Google Scholar
• Liao P, Hemmerlin A, Bach TJ, Chye ML. The potential of the mevalonate pathway for enhanced isoprenoid production. Biotechnol Adv. 2016;34(5):697–713. doi:10.1016/j.biotechadv.2016.03.005
   PubMed Web of Science ®Google Scholar
• Lee J, Roh JL. Targeting GPX4 in human cancer: implications of ferroptosis induction for tackling cancer resilience. Cancer Lett. 2023;559:216119. doi:10.1016/j.canlet.2023.216119
   PubMed Web of Science ®Google Scholar
• Zheng J, Conrad M. The Metabolic Underpinnings of Ferroptosis. Cell Metab. 2020;32(6):920–937. doi:10.1016/j.cmet.2020.10.011
   PubMed Web of Science ®Google Scholar
• Peuget S, Zhou X, Selivanova G. Translating p53-based therapies for cancer into the clinic. Nat Rev Cancer. 2024;24(3):192–215. doi:10.1038/s41568-023-00658-3
   PubMed Web of Science ®Google Scholar
• Zhao C, Yu Y, Yin G, et al. Sulfasalazine promotes ferroptosis through AKT-ERK1/2 and P53-SLC7A11 in rheumatoid arthritis. Inflammopharmacology. 2024;32:1277–1294. doi:10.1007/s10787-024-01439-6
   PubMed Web of Science ®Google Scholar
• Liu C, Shen Y, Cavdar O, Huang J, Fang H. Angiotensin II-induced vascular endothelial cells ferroptosis via P53-ALOX12 signal axis. Clin Exp Hypertens. 2023;45(1):2180019. doi:10.1080/10641963.2023.2180019
   PubMed Web of Science ®Google Scholar
• Zhu T, Liu B, Wu D, Xu G, Fan Y. Autophagy regulates VDAC3 Ubiquitination by FBXW7 to promote erastin-induced ferroptosis in acute lymphoblastic leukemia. Front Cell Dev Biol. 2021;9:740884. doi:10.3389/fcell.2021.740884
   PubMed Web of Science ®Google Scholar
• Luo M, Wu L, Zhang K, et al. miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma. Cell Death Differ. 2018;25(8):1457–1472. doi:10.1038/s41418-017-0053-8
   PubMed Web of Science ®Google Scholar
• Sun X, Ou Z, Chen R, et al. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology. 2016;63(1):173–184. doi:10.1002/hep.28251
   PubMed Web of Science ®Google Scholar
• Yang WS, SriRamaratnam R, Welsch ME, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156(1–2):317–331. doi:10.1016/j.cell.2013.12.010
   PubMed Web of Science ®Google Scholar
• Ferrada L, Barahona MJ, Vera M, Stockwell BR, Nualart F. Dehydroascorbic acid sensitizes cancer cells to system x(c)(-) inhibition-induced ferroptosis by promoting lipid droplet peroxidation. Cell Death Dis. 2023;14(9):637. doi:10.1038/s41419-023-06153-9
   PubMed Web of Science ®Google Scholar
• Fang Y, Tan Q, Zhou H, Xu J, Gu Q. Discovery and optimization of 2-(trifluoromethyl)benzimidazole derivatives as novel ferroptosis inducers in vitro and in vivo. Eur J Med Chem. 2023;245(Pt 1):114905. doi:10.1016/j.ejmech.2022.114905
   PubMedGoogle Scholar
• Wang W, Ma F, Cheung YT, et al. Marine alkaloid lepadins E and H induce ferroptosis for cancer chemotherapy. J Med Chem. 2023;66(16):11201–11215. doi:10.1021/acs.jmedchem.3c00659
   PubMed Web of Science ®Google Scholar
• Yin LB, Li ZW, Wang JL, et al. Sulfasalazine inhibits esophageal cancer cell proliferation by mediating ferroptosis. Chem Biol Drug Des. 2023;102(4):730–737. doi:10.1111/cbdd.14281
   PubMed Web of Science ®Google Scholar
• Zhang D, Zhang M, Pang Y, Li M, Ma W. Folic acid-modified long-circulating liposomes loaded with sulfasalazine for targeted induction of ferroptosis in melanoma. ACS Biomater Sci Eng. 2024;10(1):588–598. doi:10.1021/acsbiomaterials.3c01223
   PubMed Web of Science ®Google Scholar
• Ignarro RS, Facchini G, Vieira AS, et al. Sulfasalazine intensifies temozolomide cytotoxicity in human glioblastoma cells. Mol Cell Biochem. 2016;418(1–2):167–178. doi:10.1007/s11010-016-2742-x
   PubMed Web of Science ®Google Scholar
• Guo L, Hu C, Yao M, Han G. Mechanism of sorafenib resistance associated with ferroptosis in HCC. Front Pharmacol. 2023;14:1207496. doi:10.3389/fphar.2023.1207496
   PubMed Web of Science ®Google Scholar
• Zhou X, Zou L, Chen W, et al. Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer. Pharmacol Res. 2021;164:105305. doi:10.1016/j.phrs.2020.105305
   PubMed Web of Science ®Google Scholar
• Zhang J, Gao M, Niu Y, Sun J. From DNMT1 degrader to ferroptosis promoter: drug repositioning of 6-Thioguanine as a ferroptosis inducer in gastric cancer. Biochem Biophys Res Commun. 2022;603:75–81. doi:10.1016/j.bbrc.2022.03.026
   PubMed Web of Science ®Google Scholar
• Yang J, Zhou Y, Xie S, et al. Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer. J Exp Clin Cancer Res. 2021;40(1):206. doi:10.1186/s13046-021-02012-7
   PubMed Web of Science ®Google Scholar
• Deng C, Xiong L, Chen Y, Wu K, Wu J. Metformin induces ferroptosis through the Nrf2/HO-1 signaling in lung cancer. BMC Pulm Med. 2023;23(1):360. doi:10.1186/s12890-023-02655-6
   PubMed Web of Science ®Google Scholar
• Liang X, Hu C, Han M, et al. Solasonine inhibits pancreatic cancer progression with involvement of ferroptosis induction. Front Oncol. 2022;12:834729. doi:10.3389/fonc.2022.834729
   PubMed Web of Science ®Google Scholar
• Cui X, Gong Y, Ge J, et al. α-Solanine induces ferroptosis in nasopharyngeal carcinoma via targeting HSP90α/p53 axis. J Funct Foods. 2023;104:105517. doi:10.1016/j.jff.2023.105517
   Web of Science ®Google Scholar
• Tang X, Ding H, Liang M, et al. Curcumin induces ferroptosis in non-small-cell lung cancer via activating autophagy. Thorac Cancer. 2021;12(8):1219–1230. doi:10.1111/1759-7714.13904
   PubMed Web of Science ®Google Scholar
• Cao X, Li Y, Wang Y, et al. Curcumin suppresses tumorigenesis by ferroptosis in breast cancer. PLoS One. 2022;17(1):e0261370. doi:10.1371/journal.pone.0261370
   PubMed Web of Science ®Google Scholar
• Li S, He Y, Chen K, et al. RSL3 Drives Ferroptosis through NF-κB pathway activation and GPX4 depletion in glioblastoma. Oxid Med Cell Longev. 2021;2021:2915019. doi:10.1155/2021/2915019
   PubMed Web of Science ®Google Scholar
• Xing K, Bian X, Shi D, et al. miR-612 Enhances RSL3-Induced Ferroptosis of Hepatocellular Carcinoma Cells via Mevalonate Pathway. J Hepatocell Carcinoma. 2023;10:2173–2185. doi:10.2147/jhc.S433332
   PubMed Web of Science ®Google Scholar
• Xu C, Xiao Z, Wang J, et al. Discovery of a potent glutathione peroxidase 4 inhibitor as a selective ferroptosis inducer. J Med Chem. 2021;64(18):13312–13326. doi:10.1021/acs.jmedchem.1c00569
   PubMed Web of Science ®Google Scholar
• Randolph JT, O’Connor MJ, Han F, et al. Discovery of a potent chloroacetamide GPX4 inhibitor with bioavailability to enable target engagement in mice, a potential tool compound for inducing ferroptosis in vivo. J Med Chem. 2023;66(6):3852–3865. doi:10.1021/acs.jmedchem.2c01415
   PubMed Web of Science ®Google Scholar
• Weïwer M, Bittker JA, Lewis TA, et al. Development of small-molecule probes that selectively kill cells induced to express mutant RAS. Bioorg Med Chem Lett. 2012;22(4):1822–1826. doi:10.1016/j.bmcl.2011.09.047
   PubMed Web of Science ®Google Scholar
• Chen T, Leng J, Tan J, et al. Discovery of novel potent covalent glutathione peroxidase 4 inhibitors as highly selective ferroptosis inducers for the treatment of triple-negative breast cancer. J Med Chem. 2023;66(14):10036–10059. doi:10.1021/acs.jmedchem.3c00967
   PubMed Web of Science ®Google Scholar
• Zhang X, Guo Y, Li H, Han L. FIN56, a novel ferroptosis inducer, triggers lysosomal membrane permeabilization in a TFEB-dependent manner in glioblastoma. J Cancer. 2021;12(22):6610–6619. doi:10.7150/jca.58500
   PubMed Web of Science ®Google Scholar
• Liu J, Li J, Kang R, Tang D. Cell type-specific induction of ferroptosis to boost antitumor immunity. Oncoimmunology. 2023;12(1):2282252. doi:10.1080/2162402x.2023.2282252
   PubMed Web of Science ®Google Scholar
• Cao Y, Wu B, Xu Y, et al. Discovery of GPX4 inhibitors through FP-based high-throughput screening. Eur J Med Chem. 2024;265:116044. doi:10.1016/j.ejmech.2023.116044
   PubMed Web of Science ®Google Scholar
• Liu H, Forouhar F, Lin AJ, et al. Small-molecule allosteric inhibitors of GPX4. Cell Chem Biol. 2022;29(12):1680–1693.e9. doi:10.1016/j.chembiol.2022.11.003
   PubMed Web of Science ®Google Scholar
• Wang L, Cai H, Hu Y, et al. A pharmacological probe identifies cystathionine β-synthase as a new negative regulator for ferroptosis. Cell Death Dis. 2018;9(10):1005. doi:10.1038/s41419-018-1063-2
   PubMedGoogle Scholar
• Rodman SN, Spence JM, Ronnfeldt TJ, et al. Enhancement of radiation response in breast cancer stem cells by inhibition of thioredoxin- and glutathione-dependent metabolism. Radiat Res. 2016;186(4):385–395. doi:10.1667/rr14463.1
   PubMed Web of Science ®Google Scholar
• Kitsugi K, Noritake H, Matsumoto M, et al. Simvastatin inhibits hepatic stellate cells activation by regulating the ferroptosis signaling pathway. Biochim Biophys Acta Mol Basis Dis. 2023;1869(7):166750. doi:10.1016/j.bbadis.2023.166750
   PubMed Web of Science ®Google Scholar
• Shueng PW, Chan HW, Lin WC, Kuo DY, Chuang HY. Orlistat resensitizes sorafenib-resistance in hepatocellular carcinoma cells through modulating metabolism. Int J Mol Sci. 2022;23(12):6501. doi:10.3390/ijms23126501
   PubMed Web of Science ®Google Scholar
• Zhou W, Zhang J, Yan M, et al. Orlistat induces ferroptosis-like cell death of lung cancer cells. Front Med. 2021;15(6):922–932. doi:10.1007/s11684-020-0804-7
   PubMed Web of Science ®Google Scholar
• Lee J, Roh JL. Targeting Nrf2 for ferroptosis-based therapy: implications for overcoming ferroptosis evasion and therapy resistance in cancer. Biochim Biophys Acta Mol Basis Dis. 2023;1869(7):166788. doi:10.1016/j.bbadis.2023.166788
   PubMed Web of Science ®Google Scholar
• Chen H, Zhao R, Ge M, Sun Y, Li Y, Shan L. Gliotoxin, a natural product with ferroptosis inducing properties. Bioorg Chem. 2023;133:106415. doi:10.1016/j.bioorg.2023.106415
   PubMed Web of Science ®Google Scholar
• Zhou C, Yu T, Zhu R, et al. Timosaponin AIII promotes non-small-cell lung cancer ferroptosis through targeting and facilitating HSP90 mediated GPX4 ubiquitination and degradation. Int J Biol Sci. 2023;19(5):1471–1489. doi:10.7150/ijbs.77979
   PubMed Web of Science ®Google Scholar
• Zhu JM, Chen C, Kong M, et al. Discovery and optimization of indirubin derivatives as novel ferroptosis inducers for the treatment of colon cancer. Eur J Med Chem. 2023;261:115829. doi:10.1016/j.ejmech.2023.115829
   PubMed Web of Science ®Google Scholar
• Greco G, Schnekenburger M, Catanzaro E, et al. Discovery of sulforaphane as an inducer of ferroptosis in U-937 leukemia cells: expanding its anticancer potential. Cancers. 2021;14(1):76. doi:10.3390/cancers14010076
   PubMed Web of Science ®Google Scholar
• Cheu JW, Lee D, Li Q, et al. Ferroptosis suppressor protein 1 inhibition promotes tumor ferroptosis and anti-tumor immune responses in liver cancer. Cell Mol Gastroenterol Hepatol. 2023;16(1):133–159. doi:10.1016/j.jcmgh.2023.03.001
   PubMed Web of Science ®Google Scholar
• Nakamura T, Hipp C, Santos Dias Mourão A, et al.. Phase separation of FSP1 promotes ferroptosis. Nature. 2023:619(7969):371–377. doi:10.1038/s41586-023-06255-6
   Web of Science ®Google Scholar
• Hendricks JM, Doubravsky CE, Wehri E, et al. Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis. Cell Chem Biol. 2023;30(9):1090–1103.e7. doi:10.1016/j.chembiol.2023.04.007
   PubMed Web of Science ®Google Scholar
• Nakamura T, Mishima E, Yamada N, et al. Integrated chemical and genetic screens unveil FSP1 mechanisms of ferroptosis regulation. Nat Struct Mol Biol. 2023;30(11):1806–1815. doi:10.1038/s41594-023-01136-y
   PubMed Web of Science ®Google Scholar
• Yoshioka H, Kawamura T, Muroi M, et al. Identification of a small molecule that enhances ferroptosis via inhibition of ferroptosis suppressor protein 1 (FSP1). ACS Chem Biol. 2022;17(2):483–491. doi:10.1021/acschembio.2c00028
   PubMed Web of Science ®Google Scholar
• Chen J, Zhou S, Zhang X, Zhao H. S-3’-hydroxy-7’, 2’, 4’-trimethoxyisoxane, a novel ferroptosis inducer, promotes NSCLC cell death through inhibiting Nrf2/HO-1 signaling pathway. Front Pharmacol. 2022;13:973611. doi:10.3389/fphar.2022.973611
   PubMed Web of Science ®Google Scholar
• Gjorgieva Ackova D, Maksimova V, Smilkov K, Buttari B, Arese M, Saso L. Alkaloids as Natural NRF2 inhibitors: chemoprevention and cytotoxic action in cancer. Pharmaceuticals (Basel). 2023;16:6.
   Google Scholar
• Gai C, Yu M, Li Z, et al. Acetaminophen sensitizing erastin-induced ferroptosis via modulation of Nrf2/heme oxygenase-1 signaling pathway in non-small-cell lung cancer. J Cell Physiol. 2020;235(4):3329–3339. doi:10.1002/jcp.29221
   PubMed Web of Science ®Google Scholar
• Liu J, Lin WP, Su W, et al. Sunitinib attenuates reactive MDSCs enhancing anti-tumor immunity in HNSCC. Int Immunopharmacol. 2023;119:110243. doi:10.1016/j.intimp.2023.110243
   PubMed Web of Science ®Google Scholar
• Kong N, Chen X, Feng J, et al. Baicalin induces ferroptosis in bladder cancer cells by downregulating FTH1. Acta Pharm Sin B. 2021;11(12):4045–4054. doi:10.1016/j.apsb.2021.03.036
   PubMed Web of Science ®Google Scholar
• Li J, Wei S, Marabada D, Wang Z, Huang Q. Research Progress of Natural Matrine Compounds and Synthetic Matrine Derivatives. Molecules. 2023;28(15):1.
   Web of Science ®Google Scholar
• Zhu X, Chen X, Qiu L, Zhu J, Wang J. Norcantharidin induces ferroptosis via the suppression of NRF2/HO-1 signaling in ovarian cancer cells. Oncol Lett. 2022;24(4):359. doi:10.3892/ol.2022.13479
   PubMed Web of Science ®Google Scholar
• Liu X, Peng X, Cen S, Yang C, Ma Z, Shi X. Wogonin induces ferroptosis in pancreatic cancer cells by inhibiting the Nrf2/GPX4 axis. Front Pharmacol. 2023;14:1129662. doi:10.3389/fphar.2023.1129662
   PubMed Web of Science ®Google Scholar
• Liu J, Yang G, Zhang H. Glyphosate-triggered hepatocyte ferroptosis via suppressing Nrf2/GSH/GPX4 axis exacerbates hepatotoxicity. Sci Total Environ. 2023;862:160839. doi:10.1016/j.scitotenv.2022.160839
   PubMed Web of Science ®Google Scholar
• He X, Zhou Y, Chen W, et al. Repurposed pizotifen malate targeting NRF2 exhibits anti-tumor activity through inducing ferroptosis in esophageal squamous cell carcinoma. Oncogene. 2023;42(15):1209–1223. doi:10.1038/s41388-023-02636-3
   PubMed Web of Science ®Google Scholar
• Zhu X, Huang N, Ji Y, et al. Brusatol induces ferroptosis in oesophageal squamous cell carcinoma by repressing GSH synthesis and increasing the labile iron pool via inhibition of the NRF2 pathway. Biomed Pharmacother. 2023;167:115567. doi:10.1016/j.biopha.2023.115567
   PubMed Web of Science ®Google Scholar
• Ma S, Henson ES, Chen Y, Gibson SB. Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells. Cell Death Dis. 2016;7(7):e2307. doi:10.1038/cddis.2016.208
   PubMed Web of Science ®Google Scholar
• Xiang Y, Chen X, Wang W, et al. Natural product erianin inhibits bladder cancer cell growth by inducing ferroptosis via NRF2 inactivation. Front Pharmacol. 2021;12:775506. doi:10.3389/fphar.2021.775506
   PubMed Web of Science ®Google Scholar
• Li ZJ, Dai HQ, Huang XW, et al. Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma. Acta Pharmacol Sin. 2021;42(2):301–310. doi:10.1038/s41401-020-0478-3
   PubMed Web of Science ®Google Scholar
• Kuang Y, Sechi M, Nurra S, Ljungman M, Neamati N. Design and Synthesis of Novel Reactive Oxygen Species Inducers for the Treatment of Pancreatic Ductal Adenocarcinoma. J Med Chem. 2018;61(4):1576–1594. doi:10.1021/acs.jmedchem.7b01463
   PubMed Web of Science ®Google Scholar
• Platzbecker U, Santini V, Fenaux P, et al. Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2024;403(10423):249–260. doi:10.1016/s0140-6736(23)01724-5
   PubMed Web of Science ®Google Scholar
• Qiu C, Zhang X, Huang B, et al. Disulfiram, a ferroptosis inducer, triggers lysosomal membrane permeabilization by up-regulating ROS in glioblastoma. Onco Targets Ther. 2020;13:10631–10640. doi:10.2147/ott.S272312
   PubMed Web of Science ®Google Scholar
• Cruz-Gregorio A, Aranda-Rivera AK. Quercetin and Ferroptosis. Life. 2023;13(8):1.
   Google Scholar
• Oh M, Jang SY, Lee JY, et al. The lipoprotein-associated phospholipase A2 inhibitor Darapladib sensitises cancer cells to ferroptosis by remodelling lipid metabolism. Nat Commun. 2023;14(1):5728. doi:10.1038/s41467-023-41462-9
   PubMed Web of Science ®Google Scholar
• Yang L, Wang H, Yang X, et al. Auranofin mitigates systemic iron overload and induces ferroptosis via distinct mechanisms. Signal Transduct Target Ther. 2020;5(1):138. doi:10.1038/s41392-020-00253-0
   PubMed Web of Science ®Google Scholar
• Zhao H, Zhang M, Zhang J, et al. Hinokitiol-iron complex is a ferroptosis inducer to inhibit triple-negative breast tumor growth. Cell Biosci. 2023;13(1):87. doi:10.1186/s13578-023-01044-0
   PubMed Web of Science ®Google Scholar
• Huang D, Dong X, Li J, et al. Steroidal saponin SSPH I induces ferroptosis in HepG2 cells via regulating iron metabolism. Med Oncol. 2023;40(5):132. doi:10.1007/s12032-023-02000-1
   PubMed Web of Science ®Google Scholar
• Hu C, Zu D, Xu J, et al. Polyphyllin B suppresses gastric tumor growth by modulating iron metabolism and inducing ferroptosis. Int J Biol Sci. 2023;19(4):1063–1079. doi:10.7150/ijbs.80324
   PubMed Web of Science ®Google Scholar
• Wang S, Ren H, Fan C, Lin Q, Liu M, Tian J. Ochratoxin A induces renal cell ferroptosis by disrupting iron homeostasis and increasing ROS. J Agric Food Chem. 2024;72(3):1734–1744. doi:10.1021/acs.jafc.3c04495
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yang Y, Chen W, et al. BaP/BPDE suppressed endothelial cell angiogenesis to induce miscarriage by promoting MARCHF1/GPX4-mediated ferroptosis. Environ Int. 2023;180:108237. doi:10.1016/j.envint.2023.108237
   PubMed Web of Science ®Google Scholar
• Du J, Krishnamoorthy K, Ramabhai V, Yang D. Targeting ferroptosis as a therapeutic implication in lung cancer treatment by a novel naphthoquinone inducer: juglone. Mol Biotechnol. 2023. doi:10.1007/s12033-023-01004-6
   Web of Science ®Google Scholar
• Zhang Y, Tan Y, Liu S, et al. Implications of Withaferin A for the metastatic potential and drug resistance in hepatocellular carcinoma cells via Nrf2-mediated EMT and ferroptosis. Toxicol Mech Methods. 2023;33(1):47–55. doi:10.1080/15376516.2022.2075297
   PubMed Web of Science ®Google Scholar
• Liang T, Dong H, Wang Z, et al. Discovery of novel urea derivatives as ferroptosis and autophagy inducer for human colon cancer treatment. Eur J Med Chem. 2024;268:116277. doi:10.1016/j.ejmech.2024.116277
   PubMed Web of Science ®Google Scholar
• Kim YJ, Lim B, Kim SY, et al. Remodeling of sorafenib as an orally bioavailable ferroptosis inducer for Lung Cancer by chemical modification of adenine-binding motif. Biomed Pharmacother. 2024;176:116758. doi:10.1016/j.biopha.2024.116758
   PubMedGoogle Scholar
• Ma F, Li Y, Cai M, et al. ML162 derivatives incorporating a naphthoquinone unit as ferroptosis/apoptosis inducers: design, synthesis, anti-cancer activity, and drug-resistance reversal evaluation. Eur J Med Chem. 2024;270:116387. doi:10.1016/j.ejmech.2024.116387
   PubMed Web of Science ®Google Scholar
• Wang R, Song W, Zhu J, et al. Biomimetic nano-chelate diethyldithiocarbamate Cu/Fe for enhanced metalloimmunity and ferroptosis activation in glioma therapy. J Control Release. 2024;368:84–96. doi:10.1016/j.jconrel.2024.02.004
   PubMed Web of Science ®Google Scholar
• Zheng Z, Zhang S, Liu X, et al.. LRRK2 regulates ferroptosis through the system Xc-GSH-GPX4 pathway in the neuroinflammatory mechanism of Parkinson’s disease. J Cell Physiol. 2024;239. doi:10.1002/jcp.31250
   Web of Science ®Google Scholar
• Dolma S, Lessnick SL, Hahn WC, Stockwell BR. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell. 2003;3(3):285–296. doi:10.1016/s1535-6108(03)00050-3
   PubMed Web of Science ®Google Scholar
• Zhang W, Li Q, Zhang Y, et al. Multiple myeloma with high expression of SLC7A11 is sensitive to erastin-induced ferroptosis. Apoptosis. 2024;29(3–4):412–423. doi:10.1007/s10495-023-01909-2
   PubMed Web of Science ®Google Scholar
• Huo H, Zhou Z, Qin J, Liu W, Wang B, Gu Y. Erastin disrupts mitochondrial permeability transition pore (mPTP) and induces apoptotic death of colorectal cancer cells. PLoS One. 2016;11(5):e0154605. doi:10.1371/journal.pone.0154605
   PubMed Web of Science ®Google Scholar
• Yu Y, Xie Y, Cao L, et al. The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents. Mol Cell Oncol. 2015;2(4):e1054549. doi:10.1080/23723556.2015.1054549
   PubMed Web of Science ®Google Scholar
• Li Y, Zeng X, Lu D, Yin M, Shan M, Gao Y. Erastin induces ferroptosis via ferroportin-mediated iron accumulation in endometriosis. Hum Reprod. 2021;36(4):951–964. doi:10.1093/humrep/deaa363
   PubMed Web of Science ®Google Scholar
• Song J, Wang H, Sheng J, et al. Vitexin attenuates chronic kidney disease by inhibiting renal tubular epithelial cell ferroptosis via NRF2 activation. Mol Med. 2023;29(1):147. doi:10.1186/s10020-023-00735-1
   PubMed Web of Science ®Google Scholar
• Xu C, Li S, Chen J, et al. Doxorubicin and erastin co-loaded hydroxyethyl starch-polycaprolactone nanoparticles for synergistic cancer therapy. J Control Release. 2023;356:256–271. doi:10.1016/j.jconrel.2023.03.001
   PubMed Web of Science ®Google Scholar
• Cheng Q, Bao L, Li M, Chang K, Yi X. Erastin synergizes with cisplatin via ferroptosis to inhibit ovarian cancer growth in vitro and in vivo. J Obstet Gynaecol Res. 2021;47(7):2481–2491. doi:10.1111/jog.14779
   PubMed Web of Science ®Google Scholar
• Chen L, Li X, Liu L, Yu B, Xue Y, Liu Y. Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function. Oncol Rep. 2015;33(3):1465–1474. doi:10.3892/or.2015.3712
   PubMed Web of Science ®Google Scholar
• Woodley K, Dillingh LS, Giotopoulos G, et al. Mannose metabolism inhibition sensitizes acute myeloid leukaemia cells to therapy by driving ferroptotic cell death. Nat Commun. 2023;14(1):2132. doi:10.1038/s41467-023-37652-0
   PubMed Web of Science ®Google Scholar
• Liu ZY, Chen G, Wang X, et al. Synergistic photochemo effects based on light-activatable dual prodrug nanoparticles for effective cancer therapy. Adv Healthc Mater. 2023;12(27):e2301133. doi:10.1002/adhm.202301133
   PubMed Web of Science ®Google Scholar
• Larraufie MH, Yang WS, Jiang E, Thomas AG, Slusher BS, Stockwell BR. Incorporation of metabolically stable ketones into a small molecule probe to increase potency and water solubility. Bioorg Med Chem Lett. 2015;25(21):4787–4792. doi:10.1016/j.bmcl.2015.07.018
   PubMed Web of Science ®Google Scholar
• Zhang Y, Tan H, Daniels JD, et al. Imidazole ketone erastin induces ferroptosis and slows tumor growth in a mouse lymphoma model. Cell Chem Biol. 2019;26(5):623–633.e9. doi:10.1016/j.chembiol.2019.01.008
   PubMed Web of Science ®Google Scholar
• Nuzzo G, Gallo C, Crocetta F, et al. Identification of the marine alkaloid lepadin a as potential inducer of immunogenic cell death. Biomolecules. 2022;12(2):246. doi:10.3390/biom12020246
   PubMed Web of Science ®Google Scholar
• Zhou J, Wu J, Fu F, et al. α-Solanine attenuates chondrocyte pyroptosis to improve osteoarthritis via suppressing NF-κB pathway. J Cell Mol Med. 2024;28(4):e18132. doi:10.1111/jcmm.18132
   PubMed Web of Science ®Google Scholar
• Fekry MI, Ezzat SM, Salama MM, Alshehri OY, Al-Abd AM. Bioactive glycoalkaloides isolated from Solanum melongena fruit peels with potential anticancer properties against hepatocellular carcinoma cells. Sci Rep. 2019;9(1):1746. doi:10.1038/s41598-018-36089-6
   PubMedGoogle Scholar
• Zou T, Gu L, Yang L, et al. Alpha-solanine anti-tumor effects in non-small cell lung cancer through regulating the energy metabolism pathway. Recent Pat Anticancer Drug Discov. 2022;17(4):396–409. doi:10.2174/1574892817666220113144635
   PubMed Web of Science ®Google Scholar
• Li TC, Chen NJ, Chen YY, He BJ, Zhou ZF. Solasonine induces apoptosis of the SGC-7901 human gastric cancer cell line in vitro via the mitochondria-mediated pathway. J Cell Mol Med. 2022;26(12):3387–3395. doi:10.1111/jcmm.17343
   PubMed Web of Science ®Google Scholar
• Zeng YY, Luo YB, Ju XD, et al. Solasonine causes redox imbalance and mitochondrial oxidative stress of ferroptosis in lung adenocarcinoma. Front Oncol. 2022;12:874900. doi:10.3389/fonc.2022.874900
   PubMed Web of Science ®Google Scholar
• Jin M, Shi C, Li T, Wu Y, Hu C, Huang G. Solasonine promotes ferroptosis of hepatoma carcinoma cells via glutathione peroxidase 4-induced destruction of the glutathione redox system. Biomed Pharmacother. 2020;129:110282. doi:10.1016/j.biopha.2020.110282
   PubMed Web of Science ®Google Scholar
• Gao TH, Liao W, Lin LT, et al. Curcumae rhizoma and its major constituents against hepatobiliary disease: pharmacotherapeutic properties and potential clinical applications. Phytomedicine. 2022;102:154090. doi:10.1016/j.phymed.2022.154090
   PubMed Web of Science ®Google Scholar
• Hesari A, Rezaei M, Rezaei M, et al. Effect of curcumin on glioblastoma cells. J Cell Physiol. 2019;234(7):10281–10288. doi:10.1002/jcp.27933
   PubMed Web of Science ®Google Scholar
• Chen H, Li Z, Xu J, et al. Curcumin induces ferroptosis in follicular thyroid cancer by upregulating HO-1 expression. Oxid Med Cell Longev. 2023;2023:6896790. doi:10.1155/2023/6896790
   PubMed Web of Science ®Google Scholar
• Zheng Y, Zhao T, Wang J, et al. Curcumol alleviates liver fibrosis through inducing autophagy and ferroptosis in hepatic stellate cells. FASEB j. 2022;36(12):e22665. doi:10.1096/fj.202200933RR
   PubMed Web of Science ®Google Scholar
• Cheng HP, Bao XW, Luo YY, et al. Sulfasalazine ameliorates lipopolysaccharide-induced acute lung injury by inhibiting oxidative stress and nuclear factor-kappaB pathways. Int J Biochem Cell Biol. 2024;169:106530. doi:10.1016/j.biocel.2024.106530
   PubMed Web of Science ®Google Scholar
• Wang F, Oudaert I, Tu C, et al. System Xc(-) inhibition blocks bone marrow-multiple myeloma exosomal crosstalk, thereby countering bortezomib resistance. Cancer Lett. 2022;535:215649. doi:10.1016/j.canlet.2022.215649
   PubMed Web of Science ®Google Scholar
• Takatani-Nakase T, Ikushima C, Sakitani M, Nakase I. Regulatory network of ferroptosis and autophagy by targeting oxidative stress defense using sulfasalazine in triple-negative breast cancer. Life Sci. 2024;339:122411. doi:10.1016/j.lfs.2023.122411
   PubMed Web of Science ®Google Scholar
• Giannitrapani L, Di Gaudio F, Cervello M, et al. Genetic biomarkers of sorafenib response in patients with hepatocellular carcinoma. Int J Mol Sci. 2024;25(4):2197. doi:10.3390/ijms25042197
   PubMed Web of Science ®Google Scholar
• Yuan S, Wei C, Liu G, et al. Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1α/SLC7A11 pathway. Cell Prolif. 2022;55(1):e13158. doi:10.1111/cpr.13158
   PubMed Web of Science ®Google Scholar
• Zheng J, Sato M, Mishima E, Sato H, Proneth B, Conrad M. Sorafenib fails to trigger ferroptosis across a wide range of cancer cell lines. Cell Death Dis. 2021;12(7):698. doi:10.1038/s41419-021-03998-w
   PubMed Web of Science ®Google Scholar
• Hong T, Lei G, Chen X, et al. PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer. Redox Biol. 2021;42:101928. doi:10.1016/j.redox.2021.101928
   PubMed Web of Science ®Google Scholar
• Yang WS, Stockwell BR. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol. 2008;15(3):234–245. doi:10.1016/j.chembiol.2008.02.010
   PubMedGoogle Scholar
• Sui X, Zhang R, Liu S, et al. RSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal Cancer. Front Pharmacol. 2018;9:1371. doi:10.3389/fphar.2018.01371
   PubMed Web of Science ®Google Scholar
• Chen H, Qi Q, Wu N, et al. Aspirin promotes RSL3-induced ferroptosis by suppressing mTOR/SREBP-1/SCD1-mediated lipogenesis in PIK3CA-mutant colorectal cancer. Redox Biol. 2022;55:102426. doi:10.1016/j.redox.2022.102426
   PubMed Web of Science ®Google Scholar
• Cheff DM, Huang C, Scholzen KC, et al. The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1. Redox Biol. 2023;62:102703. doi:10.1016/j.redox.2023.102703
   PubMed Web of Science ®Google Scholar
• Liu S, Wu W, Chen Q, et al. TXNRD1: a key regulator involved in the ferroptosis of CML cells induced by cysteine depletion in vitro. Oxid Med Cell Longev. 2021;2021:7674565. doi:10.1155/2021/7674565
   PubMed Web of Science ®Google Scholar
• Eaton JK, Furst L, Ruberto RA, et al. Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles. Nat Chem Biol. 2020;16(5):497–506. doi:10.1038/s41589-020-0501-5
   PubMed Web of Science ®Google Scholar
• Hou DY, Cheng DB, Zhang NY, et al. In vivo assembly enhanced binding effect augments tumor specific ferroptosis therapy. Nat Commun. 2024;15(1):454. doi:10.1038/s41467-023-44665-2
   PubMed Web of Science ®Google Scholar
• Li J, Liu J, Zhou Z, et al. Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer. Sci Transl Med. 2023;15(720):eadg3049. doi:10.1126/scitranslmed.adg3049
   PubMed Web of Science ®Google Scholar
• Shimada K, Skouta R, Kaplan A, et al. Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis. Nat Chem Biol. 2016;12(7):497–503. doi:10.1038/nchembio.2079
   PubMed Web of Science ®Google Scholar
• Fruehauf JP, Zonis S, al-Bassam M, et al. Selective and synergistic activity of L-S, R-buthionine sulfoximine on malignant melanoma is accompanied by decreased expression of glutathione-S-transferase. Pigment Cell Res. 1997;10(4):236–249. doi:10.1111/j.1600-0749.1997.tb00490.x
   PubMedGoogle Scholar
• Ye M, Lu F, Chen J, et al. Orlistat induces ferroptosis in pancreatic neuroendocrine tumors by inactivating the MAPK pathway. J Cancer. 2023;14(8):1458–1469. doi:10.7150/jca.83118
   PubMed Web of Science ®Google Scholar
• Liu S, Zhang HL, Li J, et al. Tubastatin A potently inhibits GPX4 activity to potentiate cancer radiotherapy through boosting ferroptosis. Redox Biol. 2023;62:102677. doi:10.1016/j.redox.2023.102677
   PubMed Web of Science ®Google Scholar
• Baralić K, Živanović J, Marić Đ, et al. Sulforaphane-A compound with potential health benefits for disease prevention and treatment: insights from pharmacological and toxicological experimental studies. Antioxidants (Basel). 2024;13(2). doi:10.3390/antiox13020147
   PubMedGoogle Scholar
• Li W, Liang L, Liu S, Yi H, Zhou Y. FSP1: a key regulator of ferroptosis. Trends Mol Med. 2023;29(9):753–764. doi:10.1016/j.molmed.2023.05.013
   PubMed Web of Science ®Google Scholar
• Bebber CM, von Karstedt S. FSP1 inhibition: pick your pocket. Nat Struct Mol Biol. 2023;30(11):1618–1619. doi:10.1038/s41594-023-01145-x
   PubMed Web of Science ®Google Scholar
• Doll S, Freitas FP, Shah R, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575:693–698. doi:10.1038/s41586-019-1707-0
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhang L, Yan J, Hou A, Sui W, Sun M. Curcumin Induces Ferroptosis in A549 CD133(+) Cells through the GSH-GPX4 and FSP1-CoQ10-NAPH Pathways. Discov Med. 2023;35(176):251–263. doi:10.24976/Discov.Med.202335176.26
   PubMed Web of Science ®Google Scholar
• Liu MR, Shi C, Song QY, et al.. Sorafenib induces ferroptosis by promoting TRIM54-mediated FSP1 ubiquitination and degradation in hepatocellular carcinoma. Hepatol Commun. 2023;7(10). doi:10.1097/HC9.0000000000000246
   Web of Science ®Google Scholar
• Kim JW, Kim MJ, Han TH, et al. FSP1 confers ferroptosis resistance in KEAP1 mutant non-small cell lung carcinoma in NRF2-dependent and -independent manner. Cell Death Dis. 2023;14(8):567. doi:10.1038/s41419-023-06070-x
   PubMed Web of Science ®Google Scholar
• Sun S, Shen J, Jiang J, Wang F, Min J. Targeting ferroptosis opens new avenues for the development of novel therapeutics. Signal Transduct Target Ther. 2023;8(1):372. doi:10.1038/s41392-023-01606-1
   PubMed Web of Science ®Google Scholar
• Yan R, Lin B, Jin W, Tang L, Hu S, Cai R. NRF2, a Superstar of Ferroptosis. Antioxidants (Basel). 2023;12(9):1.
   Google Scholar
• Yu X, Wang Y, Tan J, et al. Inhibition of NRF2 enhances the acute myeloid leukemia cell death induced by venetoclax via the ferroptosis pathway. Cell Death Discov. 2024;10(1):35. doi:10.1038/s41420-024-01800-2
   PubMed Web of Science ®Google Scholar
• Kar A, Mukherjee SK, Barik S, Hossain ST. Antimicrobial activity of trigonelline hydrochloride against pseudomonas aeruginosa and its quorum-sensing regulated molecular mechanisms on biofilm formation and virulence. ACS Infect Dis. 2024;10(2):746–762. doi:10.1021/acsinfecdis.3c00617
   PubMed Web of Science ®Google Scholar
• Fouzder C, Mukhuty A, Mukherjee S, Malick C, Kundu R. Trigonelline inhibits Nrf2 via EGFR signalling pathway and augments efficacy of Cisplatin and Etoposide in NSCLC cells. Toxicol In Vitro. 2021;70:105038. doi:10.1016/j.tiv.2020.105038
   PubMed Web of Science ®Google Scholar
• Bajek-Bil A, Chmiel M, Włoch A, Stompor-Gorący M. Baicalin-current trends in detection methods and health-promoting properties. Pharmaceuticals (Basel). 2023;16(4):570. doi:10.3390/ph16040570
   PubMedGoogle Scholar
• Wen RJ, Dong X, Zhuang HW, et al. Baicalin induces ferroptosis in osteosarcomas through a novel Nrf2/xCT/GPX4 regulatory axis. Phytomedicine. 2023;116:154881. doi:10.1016/j.phymed.2023.154881
   PubMed Web of Science ®Google Scholar
• Jin J, Fan Z, Long Y, et al. Matrine induces ferroptosis in cervical cancer through activation of piezo1 channel. Phytomedicine. 2024;122:155165. doi:10.1016/j.phymed.2023.155165
   PubMed Web of Science ®Google Scholar
• Chen MH, Gu YY, Zhang AL, Sze DM, Mo SL, May BH. Biological effects and mechanisms of matrine and other constituents of Sophora flavescens in colorectal cancer. Pharmacol Res. 2021;171:105778. doi:10.1016/j.phrs.2021.105778
   PubMed Web of Science ®Google Scholar
• Wang X, Zhu W, Xing M, Zhu H, Chen E, Zhou J. Matrine disrupts Nrf2/GPX4 antioxidant system and promotes hepatocyte ferroptosis. Chem Biol Interact. 2023;384:110713. doi:10.1016/j.cbi.2023.110713
   PubMed Web of Science ®Google Scholar
• Zhou Y, Fan X, Jiao T, et al. SIRT6 as a key event linking P53 and NRF2 counteracts APAP-induced hepatotoxicity through inhibiting oxidative stress and promoting hepatocyte proliferation. Acta Pharm Sin B. 2021;11(1):89–99. doi:10.1016/j.apsb.2020.06.016
   PubMed Web of Science ®Google Scholar
• Yamada N, Komada T, Ohno N, Takahashi M. Acetaminophen-induced hepatotoxicity: different mechanisms of Acetaminophen-induced ferroptosis and mitochondrial damage. Arch Toxicol. 2020;94(6):2255–2257. doi:10.1007/s00204-020-02722-5
   PubMed Web of Science ®Google Scholar
• Li D, Song C, Song C, et al. Sunitinib induces cardiotoxicity through modulating oxidative stress and Nrf2-dependent ferroptosis in vitro and in vivo. Chem Biol Interact. 2024;388:110829. doi:10.1016/j.cbi.2023.110829
   PubMed Web of Science ®Google Scholar
• Bruedigam C, Porter AH, Song A, et al. Imetelstat-mediated alterations in fatty acid metabolism to induce ferroptosis as a therapeutic strategy for acute myeloid leukemia. Nat Cancer. 2024;5(1):47–65. doi:10.1038/s43018-023-00653-5
   PubMedGoogle Scholar
• Linkermann A. Telomerase inhibitor imetelstat kills AML cells via lipid ROS and ferroptosis. Nat Cancer. 2024;5(1):12–13. doi:10.1038/s43018-023-00654-4
   PubMedGoogle Scholar
• Zeng M, Wu B, Wei W, et al. Disulfiram: a novel repurposed drug for cancer therapy. Chin Med J (Engl). 2024. doi:10.1097/cm9.0000000000002909
   Google Scholar
• Xu Y, Lu L, Luo J, et al. Disulfiram alone functions as a radiosensitizer for pancreatic cancer both in vitro and in vivo. Front Oncol. 2021;11:683695. doi:10.3389/fonc.2021.683695
   PubMed Web of Science ®Google Scholar
• Wu L, Meng F, Dong L, et al. Disulfiram and BKM120 in combination with chemotherapy impede tumor progression and delay tumor recurrence in tumor initiating Cell-Rich TNBC. Sci Rep. 2019;9(1):236. doi:10.1038/s41598-018-35619-6
   PubMedGoogle Scholar
• Wang H, Dong Z, Liu J, Zhu Z, Najafi M. Mechanisms of Cancer-killing by Quercetin; A Review on Cell Death Mechanisms. Anticancer Agents Med Chem. 2023;23(9):999–1012. doi:10.2174/1871520623666230120094158
   PubMed Web of Science ®Google Scholar
• Kiran KS, Kameshwar VH, Mudnakudu Nagaraju KK, et al. Diosmin: a Daboia russelii venom PLA(2)s inhibitor- purified, and characterized from Oxalis corniculata L medicinal plant. J Ethnopharmacol. 2024;318(Pt B):116977. doi:10.1016/j.jep.2023.116977
   PubMedGoogle Scholar
• Ido Y, Muto N, Inada A, et al. Induction of apoptosis by hinokitiol, a potent iron chelator, in teratocarcinoma F9 cells is mediated through the activation of caspase-3. Cell Prolif. 1999;32(1):63–73. doi:10.1046/j.1365-2184.1999.3210063.x
   PubMed Web of Science ®Google Scholar
• Zhou JL, Huang XY, Qiu HC, et al. SSPH I, a novel anti-cancer saponin, inhibits autophagy and induces apoptosis via ROS Accumulation and ERK1/2 signaling pathway in hepatocellular carcinoma cells. Onco Targets Ther. 2020;13:5979–5991. doi:10.2147/ott.S253234
   PubMed Web of Science ®Google Scholar
• Lee HJ, Kim HD, Ryu D. Practical strategies to reduce ochratoxin A in foods. Toxins (Basel). 2024;16(1):58. doi:10.3390/toxins16010058
   PubMed Web of Science ®Google Scholar
• Zhang J, Fu M, Wu J, et al. The anti-glioma effect of juglone derivatives through ROS generation. Front Pharmacol. 2022;13:911760. doi:10.3389/fphar.2022.911760
   PubMed Web of Science ®Google Scholar
• Zhang W, Jiang B, Liu Y, Xu L, Wan M. Bufotalin induces ferroptosis in non-small cell lung cancer cells by facilitating the ubiquitination and degradation of GPX4. Free Radic Biol Med. 2022;180:75–84. doi:10.1016/j.freeradbiomed.2022.01.009
   PubMed Web of Science ®Google Scholar
• Xing Z, Su A, Mi L, et al. Withaferin A: a dietary supplement with promising potential as an anti-tumor therapeutic for cancer treatment - pharmacology and mechanisms. Drug Des Devel Ther. 2023;17:2909–2929. doi:10.2147/dddt.S422512
   PubMed Web of Science ®Google Scholar
• Du J, Wang X, Li Y, et al. DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism. Cell Death Dis. 2021;12(7):705. doi:10.1038/s41419-021-03996-y
   PubMed Web of Science ®Google Scholar
• Hsu WT, Huang CY, Yen CYT, Cheng AL, Hsieh PCH. The HER2 inhibitor lapatinib potentiates doxorubicin-induced cardiotoxicity through iNOS signaling. Theranostics. 2018;8(12):3176–3188. doi:10.7150/thno.23207
   PubMed Web of Science ®Google Scholar
• Zhang S, Liu Z, Xia T, et al. Ginkgolic acid inhibits the expression of SAE1 and induces ferroptosis to exert an anti-hepatic fibrosis effect. Phytomedicine. 2024;126:155148. doi:10.1016/j.phymed.2023.155148
   PubMed Web of Science ®Google Scholar
• Viswanadhapalli S, Luo Y, Sareddy GR, et al. EC359: a first-in-class small-molecule inhibitor for targeting oncogenic LIFR signaling in triple-negative breast cancer. Mol Cancer Ther. 2019;18(8):1341–1354. doi:10.1158/1535-7163.Mct-18-1258
   PubMed Web of Science ®Google Scholar
• Feng CZ, Li NZ, Hu XB, et al. The LIFR-targeting small molecules EC330/EC359 are potent ferroptosis inducers. Genes Dis. 2023;10(3):735–738. doi:10.1016/j.gendis.2022.10.016
   PubMed Web of Science ®Google Scholar
• Sinitsky M, Asanov M, Sinitskaya A, et al. Atorvastatin can modulate DNA damage repair in endothelial cells exposed to mitomycin C. Int J Mol Sci. 2023;24(7):6783. doi:10.3390/ijms24076783
   PubMed Web of Science ®Google Scholar
• Zhang Q, Qu H, Chen Y, et al. Atorvastatin induces mitochondria-dependent ferroptosis via the modulation of Nrf2-xCT/GPx4 Axis. Front Cell Dev Biol. 2022;10:806081. doi:10.3389/fcell.2022.806081
   PubMed Web of Science ®Google Scholar
• Warita K, Ishikawa T, Sugiura A, et al. Concomitant attenuation of HMGCR expression and activity enhances the growth inhibitory effect of atorvastatin on TGF-β-treated epithelial cancer cells. Sci Rep. 2021;11(1):12763. doi:10.1038/s41598-021-91928-3
   PubMed Web of Science ®Google Scholar
• Liu T, Shu J, Liu Y, et al. Atorvastatin attenuates ferroptosis-dependent myocardial injury and inflammation following coronary microembolization via the Hif1a/Ptgs2 pathway. Front Pharmacol. 2022;13:1057583. doi:10.3389/fphar.2022.1057583
   PubMed Web of Science ®Google Scholar
• Feng M, Xu H, Zhou W, Pan Y. The BRD4 inhibitor JQ1 augments the antitumor efficacy of abemaciclib in preclinical models of gastric carcinoma. J Exp Clin Cancer Res. 2023;42(1):44. doi:10.1186/s13046-023-02615-2
   PubMed Web of Science ®Google Scholar
• Sui S, Zhang J, Xu S, Wang Q, Wang P, Pang D. Ferritinophagy is required for the induction of ferroptosis by the bromodomain protein BRD4 inhibitor (+)-JQ1 in cancer cells. Cell Death Dis. 2019;10(5):331. doi:10.1038/s41419-019-1564-7
   PubMed Web of Science ®Google Scholar
• Go S, Kang M, Kwon SP, Jung M, Jeon OH, Kim BS. The senolytic drug JQ1 removes senescent cells via ferroptosis. Tissue Eng Regen Med. 2021;18(5):841–850. doi:10.1007/s13770-021-00346-z
   PubMed Web of Science ®Google Scholar
• Våtsveen TK, Myhre MR, Steen CB, et al. Artesunate shows potent anti-tumor activity in B-cell lymphoma. J Hematol Oncol. 2018;11(1):23. doi:10.1186/s13045-018-0561-0
   PubMedGoogle Scholar
• Ooko E, Saeed ME, Kadioglu O, et al. Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells. Phytomedicine. 2015;22(11):1045–1054. doi:10.1016/j.phymed.2015.08.002
   PubMed Web of Science ®Google Scholar
• McDowell A, Hill KS, McCorkle JR, et al.. Preclinical evaluation of artesunate as an antineoplastic agent in ovarian cancer treatment. Diagnostics (Basel). 2021;11(3):395.
   PubMedGoogle Scholar
• Roh JL, Kim EH, Jang H, Shin D. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis. Redox Biol. 2017;11:254–262. doi:10.1016/j.redox.2016.12.010
   PubMed Web of Science ®Google Scholar
• Hughes GR, Dudey AP, Hemmings AM, Chantry A. Frontiers in PROTACs. Drug Discov Today. 2021;26(10):2377–2383. doi:10.1016/j.drudis.2021.04.010
   PubMed Web of Science ®Google Scholar
• Ignatov M, Jindal A, Kotelnikov S, et al. High accuracy prediction of PROTAC complex structures. J Am Chem Soc. 2023;145(13):7123–7135. doi:10.1021/jacs.2c09387
   PubMed Web of Science ®Google Scholar
• Wang H, Wang C, Li B, et al. Discovery of ML210-Based glutathione peroxidase 4 (GPX4) degrader inducing ferroptosis of human cancer cells. Eur J Med Chem. 2023;254:115343. doi:10.1016/j.ejmech.2023.115343
   PubMed Web of Science ®Google Scholar
• Hu M, Li X, Wang L, et al. ZX703: a small-molecule degrader of GPX4 inducing ferroptosis in human cancer cells. ACS Med Chem Lett. 2024;15(3):406–412. doi:10.1021/acsmedchemlett.3c00571
   PubMed Web of Science ®Google Scholar
• Luo T, Zheng Q, Shao L, Ma T, Mao L, Wang M. Intracellular delivery of glutathione peroxidase degrader induces ferroptosis in vivo. Angew Chem Int Ed Engl. 2022;61(39):e202206277. doi:10.1002/anie.202206277
   PubMed Web of Science ®Google Scholar
• Cai M, Ma F, Hu C, et al. Design and synthesis of proteolysis-targeting chimeras (PROTACs) as degraders of glutathione peroxidase 4. Bioorg Med Chem. 2023;90:117352. doi:10.1016/j.bmc.2023.117352
   PubMed Web of Science ®Google Scholar
• Zhu L, Hu S, Yan X, et al. Ugi reaction-assisted assembly of covalent PROTACs against glutathione peroxidase 4. Bioorg Chem. 2023;134:106461. doi:10.1016/j.bioorg.2023.106461
   PubMed Web of Science ®Google Scholar
• Wang C, Zheng C, Wang H, et al. Dual degradation mechanism of GPX4 degrader in induction of ferroptosis exerting anti-resistant tumor effect. Eur J Med Chem. 2023;247:115072. doi:10.1016/j.ejmech.2022.115072
   PubMed Web of Science ®Google Scholar
• Song H, Liang J, Guo Y, et al. A potent GPX4 degrader to induce ferroptosis in HT1080 cells. Eur J Med Chem. 2024;265:116110. doi:10.1016/j.ejmech.2023.116110
   PubMed Web of Science ®Google Scholar
• Zheng C, Wang C, Sun D, et al. Structure-activity relationship study of RSL3-based GPX4 degraders and its potential noncovalent optimization. Eur J Med Chem. 2023;255:115393. doi:10.1016/j.ejmech.2023.115393
   PubMed Web of Science ®Google Scholar
• Yu J, Zhu F, Yang Y, et al. Ultrasmall iron-doped zinc oxide nanoparticles for ferroptosis assisted sono-chemodynamic cancer therapy. Colloids Surf B Biointerfaces. 2023;232:113606. doi:10.1016/j.colsurfb.2023.113606
   PubMed Web of Science ®Google Scholar
• Chen M, Shen Y, Pu Y, et al. Biomimetic inducer enabled dual ferroptosis of tumor and M2-type macrophages for enhanced tumor immunotherapy. Biomaterials. 2023;303:122386. doi:10.1016/j.biomaterials.2023.122386
   PubMed Web of Science ®Google Scholar
• Mu M, Wang Y, Zhao S, et al. Engineering a pH/glutathione-responsive tea polyphenol nanodevice as an apoptosis/ferroptosis-inducing agent. ACS Appl Bio Mater. 2020;3(7):4128–4138. doi:10.1021/acsabm.0c00225
   PubMedGoogle Scholar
• Chen Q, Ma X, Xie L, et al. Iron-based nanoparticles for MR imaging-guided ferroptosis in combination with photodynamic therapy to enhance cancer treatment. Nanoscale. 2021;13(9):4855–4870. doi:10.1039/d0nr08757b
   PubMed Web of Science ®Google Scholar
• Zeng L, Ding S, Cao Y, et al. A MOF-based potent ferroptosis inducer for enhanced radiotherapy of triple negative breast cancer. ACS Nano. 2023;17(14):13195–13210. doi:10.1021/acsnano.3c00048
   PubMed Web of Science ®Google Scholar
• Liu Z, Kang R, Yang N, et al. Tetrahydrobiopterin inhibitor-based antioxidant metabolic strategy for enhanced cancer ferroptosis-immunotherapy. J Colloid Interface Sci. 2024;658:100–113. doi:10.1016/j.jcis.2023.12.042
   PubMed Web of Science ®Google Scholar
• Zhao LX, Gong ZQ, Zhang Q, et al. Graphdiyne nanoplatforms for photothermal-ferroptosis combination therapy against glioblastoma. J Control Release. 2023;359:12–25. doi:10.1016/j.jconrel.2023.05.035
   PubMed Web of Science ®Google Scholar
• Cheng Z, Xue C, Liu M, et al. Injectable microenvironment-responsive hydrogels with redox-activatable supramolecular prodrugs mediate ferroptosis-immunotherapy for postoperative tumor treatment. Acta Biomater. 2023;169:289–305. doi:10.1016/j.actbio.2023.08.002
   PubMed Web of Science ®Google Scholar
• Yao X, Xie R, Cao Y, et al. Simvastatin induced ferroptosis for triple-negative breast cancer therapy. J Nanobiotechnology. 2021;19(1):311. doi:10.1186/s12951-021-01058-1
   PubMed Web of Science ®Google Scholar
• Wu F, Du Y, Yang J, et al. Peroxidase-like active nanomedicine with dual glutathione depletion property to restore oxaliplatin chemosensitivity and promote programmed cell death. ACS Nano. 2022;16(3):3647–3663. doi:10.1021/acsnano.1c06777
   PubMed Web of Science ®Google Scholar
• Liang Y, Peng C, Su N, et al. Tumor microenvironments self-activated cascade catalytic nanoscale metal organic frameworks as ferroptosis inducer for radiosensitization. Chem Eng J. 2022;437:135309. doi:10.1016/j.cej.2022.135309
   Web of Science ®Google Scholar
• Xu T, Ma Y, Yuan Q, et al. Enhanced ferroptosis by oxygen-boosted phototherapy based on a 2-in-1 nanoplatform of ferrous hemoglobin for tumor synergistic therapy. ACS Nano. 2020;14(3):3414–3425. doi:10.1021/acsnano.9b09426
   PubMed Web of Science ®Google Scholar
• Bao W, Liu X, Lv Y, et al. Nanolongan with multiple on-demand conversions for ferroptosis-apoptosis combined anticancer therapy. ACS Nano. 2019;13(1):260–273. doi:10.1021/acsnano.8b05602
   PubMed Web of Science ®Google Scholar
• Sang M, Luo R, Bai Y, et al. Mitochondrial membrane anchored photosensitive nano-device for lipid hydroperoxides burst and inducing ferroptosis to surmount therapy-resistant cancer. Theranostics. 2019;9(21):6209–6223. doi:10.7150/thno.36283
   PubMed Web of Science ®Google Scholar
• Wan X, Song L, Pan W, Zhong H, Li N, Tang B. Tumor-targeted cascade nanoreactor based on metal-organic frameworks for synergistic ferroptosis-starvation anticancer therapy. ACS Nano. 2020;14(9):11017–11028. doi:10.1021/acsnano.9b07789
   PubMed Web of Science ®Google Scholar
• Yao L, Zhao MM, Luo QW, et al. Carbon Quantum dots-based nanozyme from coffee induces cancer cell ferroptosis to activate antitumor immunity. ACS Nano. 2022;16(6):9228–9239. doi:10.1021/acsnano.2c01619
   PubMed Web of Science ®Google Scholar
• Zhou LL, Guan Q, Li WY, Zhang Z, Li YA, Dong YB. A ferrocene-functionalized covalent organic framework for enhancing chemodynamic therapy via redox dyshomeostasis. Small. 2021;17(32):e2101368. doi:10.1002/smll.202101368
   PubMed Web of Science ®Google Scholar
• Wang S, Li F, Qiao R, et al. Arginine-rich manganese silicate nanobubbles as a ferroptosis-inducing agent for tumor-targeted theranostics. ACS Nano. 2018;12(12):12380–12392. doi:10.1021/acsnano.8b06399
   PubMed Web of Science ®Google Scholar
• Xue CC, Li MH, Zhao Y, et al. Tumor microenvironment-activatable Fe-doxorubicin preloaded amorphous CaCO(3) nanoformulation triggers ferroptosis in target tumor cells. Sci Adv. 2020;6(18):eaax1346. doi:10.1126/sciadv.aax1346
   PubMed Web of Science ®Google Scholar
• Xu XL, Zhang NN, Shu GF, et al. A luminol-based self-illuminating nanocage as a reactive oxygen species amplifier to enhance deep tumor penetration and synergistic therapy. ACS Nano. 2021;15(12):19394–19408. doi:10.1021/acsnano.1c05891
   PubMed Web of Science ®Google Scholar
• Liang X, Chen M, Bhattarai P, Hameed S, Tang Y, Dai Z. Complementing cancer photodynamic therapy with ferroptosis through iron oxide loaded porphyrin-grafted lipid nanoparticles. ACS Nano. 2021;15(12):20164–20180. doi:10.1021/acsnano.1c08108
   PubMed Web of Science ®Google Scholar
• Xu Y, Guo Y, Zhang C, et al. Fibronectin-coated metal-phenolic networks for cooperative tumor chemo-/chemodynamic/immune therapy via enhanced ferroptosis-mediated immunogenic cell death. ACS Nano. 2022;16(1):984–996. doi:10.1021/acsnano.1c08585
   PubMed Web of Science ®Google Scholar
• Cao K, Du Y, Bao X, et al. Glutathione-bioimprinted nanoparticles targeting of N6-methyladenosine fto demethylase as a strategy against leukemic stem cells. Small. 2022;18(13):e2106558. doi:10.1002/smll.202106558
   PubMed Web of Science ®Google Scholar
• Zhang F, Li F, Lu GH, et al. Engineering magnetosomes for ferroptosis/immunomodulation synergism in cancer. ACS Nano. 2019;13(5):5662–5673. doi:10.1021/acsnano.9b00892
   PubMed Web of Science ®Google Scholar
• Tian X, Ruan L, Zhou S, et al. Appropriate Size of Fe(3)O(4) nanoparticles for cancer therapy by ferroptosis. ACS Appl Bio Mater. 2022;5(4):1692–1699. doi:10.1021/acsabm.2c00068
   PubMedGoogle Scholar
• Liu J, Li X, Chen J, et al. Arsenic-loaded biomimetic iron oxide nanoparticles for enhanced ferroptosis-inducing therapy of hepatocellular carcinoma. ACS Appl Mater Interfaces. 2023;15(5):6260–6273. doi:10.1021/acsami.2c14962
   PubMedGoogle Scholar
• Zhang Z, Wang L, Guo Z, Sun Y, Yan J. A pH-sensitive imidazole grafted polymeric micelles nanoplatform based on ROS amplification for ferroptosis-enhanced chemodynamic therapy. Colloids Surf B Biointerfaces. 2024;237:113871. doi:10.1016/j.colsurfb.2024.113871
   PubMed Web of Science ®Google Scholar
• Qi A, Wang C, Ni S, et al. Intravesical mucoadhesive hydrogel induces chemoresistant bladder cancer ferroptosis through delivering iron oxide nanoparticles in a three-tier strategy. ACS Appl Mater Interfaces. 2021;13(44):52374–52384. doi:10.1021/acsami.1c14944
   PubMed Web of Science ®Google Scholar
• Bilbao‐Asensio M, Ruiz‐de‐Angulo A, Arguinzoniz AG, et al.. Redox‐triggered nanomedicine via lymphatic delivery: inhibition of melanoma growth by ferroptosis enhancement and a Pt(IV)‐prodrug chemoimmunotherapy approach. Adv Ther. 2022;6(2):1.
   Google Scholar
• Liu Y, Pi F, He L, Yang F, Chen T. Oxygen vacancy-rich manganese nanoflowers as ferroptosis inducers for tumor radiotherapy. Small. 2024;e2310118. doi:10.1002/smll.202310118
   PubMed Web of Science ®Google Scholar
• Shao J, Zhang J, Xue K, et al. Upconversion dihydroartemisinin-loaded nanocomposites for NIR-enhanced ferroptosis of glioblastoma cells. ACS Appl Nano Mater. 2024;7(8):9106–9115. doi:10.1021/acsanm.4c00548
   Web of Science ®Google Scholar
• Xu J, Zhang W, Cai Z, et al.. Tetrahedron DNA nanostructure/iron-based nanomaterials for combined tumor therapy. Chin. Chem. Lett. 2024:109620. doi:10.1016/j.cclet.2024.109620
   Google Scholar
• Lin X, Chen H, Deng T, et al. Improved immune response for colorectal cancer therapy triggered by multifunctional nanocomposites with self-amplifying antitumor ferroptosis. ACS Appl Mater Interfaces. 2024;16(11):13481–13495. doi:10.1021/acsami.3c16813
   PubMed Web of Science ®Google Scholar
• Zhu X, Xie L, Tian J, Jiang Y, Song E, Song Y. A multi-mode Rhein-based nano-platform synergizing ferrotherapy/chemotherapy-induced immunotherapy for enhanced tumor therapy. Acta Biomater. 2024;180:383–393. doi:10.1016/j.actbio.2024.03.030
   PubMed Web of Science ®Google Scholar
• Chen Y, Li X, Luo K, et al. Hyperthermia/glutathione-triggered ferritin nanoparticles amplify the ferroptosis for synergistic tumor therapy. Mater Today Bio. 2024;26:101085. doi:10.1016/j.mtbio.2024.101085
   PubMedGoogle Scholar
• Zhao X, Leng D, Wang H, et al. An acid-responsive iron-based nanocomposite for OSCC treatment. J Dent Res. 2024;103(6):612–621. doi:10.1177/00220345241238154
   PubMed Web of Science ®Google Scholar
• Wang M, Yu A, Han W, Chen J, Lu C, Tu X. Self-assembled metal-phenolic nanocomplexes comprised of green tea catechin for tumor-specific ferroptosis. Mater Today Bio. 2024;26:101040. doi:10.1016/j.mtbio.2024.101040
   PubMedGoogle Scholar
• Zou W, Gao F, Meng Z, et al. Lactic acid responsive sequential production of hydrogen peroxide and consumption of glutathione for enhanced ferroptosis tumor therapy. J Colloid Interface Sci. 2024;663:787–800. doi:10.1016/j.jcis.2024.03.001
   PubMed Web of Science ®Google Scholar
• Zhu J, Zhao S, Zhu Y, et al. Sorafenib sensitization in tumor therapy by iron overload and AMPK activation. Nano Res. 2024. doi:10.1007/s12274-024-6602-9
   PubMed Web of Science ®Google Scholar
• Sun B, Zheng X, Zhang X, Zhang H, Jiang Y. Oxaliplatin-Loaded Mil-100(Fe) for chemotherapy-ferroptosis combined therapy for gastric cancer. ACS Omega. 2024;9(14):16676–16686. doi:10.1021/acsomega.4c00658
   PubMed Web of Science ®Google Scholar
• Zhao X, Wang X, Zhang W, et al. A ferroptosis-inducing arsenene-iridium nanoplatform for synergistic immunotherapy in pancreatic cancer. Angew Chem Int Ed Engl. 2024;63(15):e202400829. doi:10.1002/anie.202400829
   PubMed Web of Science ®Google Scholar
• Bai J, Zhang X, Zhao Z, et al.. CuO nanozymes catalyze cysteine and glutathione depletion induced ferroptosis and cuproptosis for synergistic tumor therapy. Small. 2024:e2400326. doi:10.1002/smll.202400326
   PubMed Web of Science ®Google Scholar
• Wang Y, Wu X, Bao X, Mou X. Progress in the mechanism of the effect of Fe(3)O(4) nanomaterials on ferroptosis in tumor cells. Molecules. 2023;28(11):1.
   Web of Science ®Google Scholar
• Wang S, He H, Mao Y, Zhang Y, Gu N. Advances in atherosclerosis theranostics harnessing iron oxide-based nanoparticles. Adv Sci. 2024;11(17):e2308298. doi:10.1002/advs.202308298
   Web of Science ®Google Scholar
• Gao L, Fan K, Yan X. Iron oxide nanozyme: a multifunctional enzyme mimetic for biomedical applications. Theranostics. 2017;7(13):3207–3227. doi:10.7150/thno.19738
   PubMed Web of Science ®Google Scholar
• Dadfar SM, Roemhild K, Drude NI, et al. Iron oxide nanoparticles: diagnostic, therapeutic and theranostic applications. Adv Drug Deliv Rev. 2019;138:302–325. doi:10.1016/j.addr.2019.01.005
   PubMed Web of Science ®Google Scholar
• Jalali A, Bari IJ, Salehzadeh A. Menthol conjugated magnetic iron oxide nanoparticles induce apoptosis and increase caspase-8 gene expression in gastric cancer cell line. BioNanoScience. 2024. doi:10.1007/s12668-024-01377-1
   Web of Science ®Google Scholar
• Mu QG, Lin G, Jeon M, et al. Iron oxide nanoparticle targeted chemo-immunotherapy for triple negative breast cancer. Mater Today (Kidlington). 2021;50:149–169. doi:10.1016/j.mattod.2021.08.002
   PubMedGoogle Scholar
• Jiang Q, Wang K, Zhang X, et al. Platelet membrane-camouflaged magnetic nanoparticles for ferroptosis-enhanced cancer immunotherapy. Small. 2020;16(22):e2001704. doi:10.1002/smll.202001704
   PubMed Web of Science ®Google Scholar
• Lyu Z, Kou Y, Fu Y, et al. Comparative transcriptomics revealed neurodevelopmental impairments and ferroptosis induced by extremely small iron oxide nanoparticles. Front Genet. 2024;15:1402771. doi:10.3389/fgene.2024.1402771
   PubMed Web of Science ®Google Scholar
• Biancacci I, De Lorenzi F, Theek B, et al. Monitoring EPR effect dynamics during nanotaxane treatment with theranostic polymeric micelles. Adv Sci. 2022;9(10):e2103745. doi:10.1002/advs.202103745
   Web of Science ®Google Scholar
• Lebreton V, Legeay S, Saulnier P, Lagarce F. Specificity of pharmacokinetic modeling of nanomedicines. Drug Discov Today. 2021;26(10):2259–2268. doi:10.1016/j.drudis.2021.04.017
   PubMed Web of Science ®Google Scholar
• Forgan RS. Reproducibility in research into metal-organic frameworks in nanomedicine. Communicat Mater. 2024;5(1). doi:10.1038/s43246-024-00475-7
   Google Scholar
• Alvarez N, Sevilla A. Current advances in photodynamic therapy (PDT) and the future potential of PDT-combinatorial cancer therapies. Int J Mol Sci. 2024;25(2):1023. doi:10.3390/ijms25021023
   PubMed Web of Science ®Google Scholar
• Mishchenko TA, Balalaeva IV, Vedunova MV, Krysko DV. Ferroptosis and photodynamic therapy synergism: enhancing anticancer treatment. Trends Cancer. 2021;7(6):484–487. doi:10.1016/j.trecan.2021.01.013
   PubMed Web of Science ®Google Scholar
• Huang Y, Li X, Zhang Z, Xiong L, Wang Y, Wen Y. Photodynamic therapy combined with ferroptosis is a synergistic antitumor therapy strategy. Cancers. 2023;15(20):5043. doi:10.3390/cancers15205043
   PubMed Web of Science ®Google Scholar
• Hu Q, Zhu W, Du J, et al. A GPX4-targeted photosensitizer to reverse hypoxia-induced inhibition of ferroptosis for non-small cell lung cancer therapy. Chem Sci. 2023;14(34):9095–9100. doi:10.1039/d3sc01597a
   PubMedGoogle Scholar
• Zhang Y, Liu X, Zeng L, et al. Exosomal protein angiopoietin-like 4 mediated radioresistance of lung cancer by inhibiting ferroptosis under hypoxic microenvironment. Br J Cancer. 2022;127(10):1760–1772. doi:10.1038/s41416-022-01956-7
   PubMed Web of Science ®Google Scholar
• Liu S, Zhao X, Shui S, et al. PDTAC: targeted Photodegradation of GPX4 triggers ferroptosis and potent antitumor immunity. J Med Chem. 2022;65(18):12176–12187. doi:10.1021/acs.jmedchem.2c00855
   PubMed Web of Science ®Google Scholar
• Kojima Y, Tanaka M, Sasaki M, et al. Induction of ferroptosis by photodynamic therapy and enhancement of antitumor effect with ferroptosis inducers. J Gastroenterol. 2024;59(2):81–94. doi:10.1007/s00535-023-02054-y
   PubMed Web of Science ®Google Scholar
• Tavakkoli Yaraki M, Wu M, Middha E, et al. Gold Nanostars-AIE theranostic nanodots with enhanced fluorescence and photosensitization towards effective image-guided photodynamic therapy. Nano-micro Lett. 2021;13(1):58. doi:10.1007/s40820-020-00583-2
   PubMed Web of Science ®Google Scholar
• Zhao X, Zhang J, Zhang W, et al. A chiral fluorescent Ir(iii) complex that targets the GPX4 and ErbB pathways to induce cellular ferroptosis. Chem Sci. 2023;14(5):1114–1122. doi:10.1039/d2sc06171f
   PubMed Web of Science ®Google Scholar
• Pan X, Wang H, Wang S, et al. Sonodynamic therapy (SDT): a novel strategy for cancer nanotheranostics. Sci China Life Sci. 2018;61(4):415–426. doi:10.1007/s11427-017-9262-x
   PubMed Web of Science ®Google Scholar
• Lai Y, Lu N, Ouyang A, Zhang Q, Zhang P. Ferroptosis promotes sonodynamic therapy: a platinum(ii)-indocyanine sonosensitizer. Chem Sci. 2022;13(34):9921–9926. doi:10.1039/d2sc02597c
   PubMed Web of Science ®Google Scholar
• Zhou L, Dong C, Ding L, et al. Targeting ferroptosis synergistically sensitizes apoptotic sonodynamic anti-tumor nanotherapy. Nano Today. 2021;39:101212. doi:10.1016/j.nantod.2021.101212
   Web of Science ®Google Scholar
• Oliver DMA, Reddy PH. Small molecules as therapeutic drugs for Alzheimer’s disease. Mol Cell Neurosci. 2019;96:47–62. doi:10.1016/j.mcn.2019.03.001
   PubMed Web of Science ®Google Scholar
• Zhang L, Luo YL, Xiang Y, et al.. Ferroptosis inhibitors: past, present and future. Front Pharmacol. 2024;15. doi:10.3389/fphar.2024.1407335
   Web of Science ®Google Scholar
• Ma W, Hu N, Xu W, Zhao L, Tian C, Kamei KI. Ferroptosis inducers: a new frontier in cancer therapy. Bioorg Chem. 2024;146:107331. doi:10.1016/j.bioorg.2024.107331
   PubMed Web of Science ®Google Scholar
• Weng G, Shen C, Cao D, et al. PROTAC-DB: an online database of PROTACs. Nucleic Acids Res. 2021;49(D1):D1381–d1387. doi:10.1093/nar/gkaa807
   PubMed Web of Science ®Google Scholar
• Dhas N, Kudarha R, Tiwari R, et al. Recent advancements in nanomaterial-mediated ferroptosis-induced cancer therapy: importance of molecular dynamics and novel strategies. Life Sci. 2024;346:122629. doi:10.1016/j.lfs.2024.122629
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu T, Li X, Sheng H, Ma X, Hao L. Ferroptosis-inducing nanomedicine for cancer therapy. Front Pharmacol. 2021;12:735965. doi:10.3389/fphar.2021.735965
   PubMed Web of Science ®Google Scholar
• Liu Q, Zhao Y, Zhou H, Chen C. Ferroptosis: challenges and opportunities for nanomaterials in cancer therapy. Regen Biomater. 2023;10:rbad004. doi:10.1093/rb/rbad004
   PubMed Web of Science ®Google Scholar
• Jiang J, Lv X, Cheng H, et al. Type I photodynamic antimicrobial therapy: principles, progress, and future perspectives. Acta Biomater. 2024;177:1–19. doi:10.1016/j.actbio.2024.02.005
   PubMed Web of Science ®Google Scholar
• Gao W, Wang Z, Lv L, et al. Photodynamic therapy induced enhancement of tumor vasculature permeability using an upconversion nanoconstruct for improved intratumoral nanoparticle delivery in deep tissues. Theranostics. 2016;6(8):1131–1144. doi:10.7150/thno.15262
   PubMed Web of Science ®Google Scholar
• Loke YL, Beishenaliev A, Wang PW, et al. ROS-generating alginate-coated gold nanorods as biocompatible nanosonosensitisers for effective sonodynamic therapy of cancer. Ultrason Sonochem. 2023;96:106437. doi:10.1016/j.ultsonch.2023.106437
   PubMed Web of Science ®Google Scholar
• Frye WJE, Huff LM, Dalmasy JMG, et al. The multidrug resistance transporter p-glycoprotein confers resistance to ferroptosis inducers. bioRxiv. 2023. doi:10.1101/2023.02.23.529736
   Google Scholar
• Liang D, Feng Y, Zandkarimi F, et al. Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell. 2023;186(13):2748–2764.e22. doi:10.1016/j.cell.2023.05.003
   PubMed Web of Science ®Google Scholar
• Li Y, Ran Q, Duan Q, et al. 7-Dehydrocholesterol dictates ferroptosis sensitivity. Nature. 2024;626(7998):411–418. doi:10.1038/s41586-023-06983-9
   PubMed Web of Science ®Google Scholar
• Du Y, Zhou Y, Yan X, et al. APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy. Cell Death Differ. 2024;31:431–446. doi:10.1038/s41418-024-01270-0
   PubMed Web of Science ®Google Scholar
• Jacinto E. mTOR takes charge: relaying uncharged tRNA levels by mTOR ubiquitination. Cell Metab. 2023;35(12):2097–2099. doi:10.1016/j.cmet.2023.11.006
   PubMed Web of Science ®Google Scholar
• Nguyen LH, Xu Y, Nair M, Bordey A. The mTOR pathway genes mTOR, Rheb, Depdc5, Pten, and Tsc1 have convergent and divergent impacts on cortical neuron development and function. bioRxiv. 2024. doi:10.1101/2023.08.11.553034
   Google Scholar
• Li S, Ouyang X, Sun H, et al. DEPDC5 protects CD8(+) T cells from ferroptosis by limiting mTORC1-mediated purine catabolism. Cell Discov. 2024;10(1):53. doi:10.1038/s41421-024-00682-z
   PubMed Web of Science ®Google Scholar
• Yang M, Luo H, Yi X, Wei X, Jiang DS. The epigenetic regulatory mechanisms of ferroptosis and its implications for biological processes and diseases. MedComm. 2023;4(3):e267. doi:10.1002/mco2.267
   PubMedGoogle Scholar
• Wang X, Kong X, Feng X, Jiang DS. Effects of DNA, RNA, and Protein Methylation on the Regulation of Ferroptosis. Int J Biol Sci. 2023;19(11):3558–3575. doi:10.7150/ijbs.85454
   PubMed Web of Science ®Google Scholar
• Pandur E, Szabó I, Hormay E, et al. Alterations of the expression levels of glucose, inflammation, and iron metabolism related miRNAs and their target genes in the hypothalamus of STZ-induced rat diabetes model. Diabetol Metab Syndr. 2022;14(1):147. doi:10.1186/s13098-022-00919-5
   PubMed Web of Science ®Google Scholar
• Murakami H, Hayashi M, Terada S, Ohmichi M. Medroxyprogesterone acetate-resistant endometrial cancer cells are susceptible to ferroptosis inducers. Life Sci. 2023;325:121753. doi:10.1016/j.lfs.2023.121753
   PubMed Web of Science ®Google Scholar
• Cai Q, Guo X, Chen Y, Liu J, Liu Y. Selenium-Doped 3D porous molybdenum carbide nanospheres improve mitochondrial function by reducing oxidative stress in alzheimer’s disease. ACS Appl Nano Mater. 2023;6(23):22496–22505. doi:10.1021/acsanm.3c05296
   Web of Science ®Google Scholar
• Xiao Y, Yu Y, Hu L, et al. Matrine alleviates sepsis-induced myocardial injury by inhibiting ferroptosis and apoptosis. Inflammation. 2023;46(5):1684–1696. doi:10.1007/s10753-023-01833-2
   PubMed Web of Science ®Google Scholar
• Sun L, Wang H, Xu D, Yu S, Zhang L, Li X. Lapatinib induces mitochondrial dysfunction to enhance oxidative stress and ferroptosis in doxorubicin-induced cardiomyocytes via inhibition of PI3K/AKT signaling pathway. Bioengineered. 2022;13(1):48–60. doi:10.1080/21655979.2021.2004980
   PubMed Web of Science ®Google Scholar
• Lei G, Mao C, Yan Y, Zhuang L, Gan B. Ferroptosis, radiotherapy, and combination therapeutic strategies. Protein Cell. 2021;12(11):836–857. doi:10.1007/s13238-021-00841-y
   PubMed Web of Science ®Google Scholar
• Nie A, Shen C, Zhou Z, Wang J, Sun B, Zhu C. Ferroptosis: potential opportunities for natural products in cancer therapy. Phytother Res. 2024;38(3):1173–1190. doi:10.1002/ptr.8088
   PubMed Web of Science ®Google Scholar
• Zhang W, Cui X, Li R, Ji W, Shi H, Cui J. Association between ICW/TBW ratio and cancer prognosis: subanalysis of a population-based retrospective multicenter study. Clin Nutr. 2024;43(2):322–331. doi:10.1016/j.clnu.2023.12.004
   PubMed Web of Science ®Google Scholar
• Alcantara M, Tesio M, June CH, Houot R. CAR T-cells for T-cell malignancies: challenges in distinguishing between therapeutic, normal, and neoplastic T-cells. Leukemia. 2018;32(11):2307–2315. doi:10.1038/s41375-018-0285-8
   PubMed Web of Science ®Google Scholar
• Wang T, Pulkkinen OI, Aittokallio T. Target-specific compound selectivity for multi-target drug discovery and repurposing. Front Pharmacol. 2022;13:1003480. doi:10.3389/fphar.2022.1003480
   PubMed Web of Science ®Google Scholar
• Huang Y, Wang J, Wang S, et al. Discrimination of active and inactive substances in cytotoxicity based on Tox21 10K compound library: structure alert and mode of action. Toxicology. 2021;462:152948. doi:10.1016/j.tox.2021.152948
   PubMed Web of Science ®Google Scholar
• Gooch A, Sizochenko N, Rasulev B, Gorb L, Leszczynski J. In vivo toxicity of nitroaromatics: a comprehensive quantitative structure-activity relationship study. Environ Toxicol Chem. 2017;36(8):2227–2233. doi:10.1002/etc.3761
   PubMed Web of Science ®Google Scholar
• Huang M, Teng Q, Cao F, Huang J, Pang J. Ferroptosis and ferroptosis-inducing nanomedicine as a promising weapon in combination therapy of prostate cancer. Biomater Sci. 2024;12:1617–1629. doi:10.1039/d3bm01894f
   PubMed Web of Science ®Google Scholar
• Liu X, Lu Y, Li X, Luo L, You J. Nanoplatform-enhanced photodynamic therapy for the induction of immunogenic cell death. J Control Release. 2024;365:1058–1073. doi:10.1016/j.jconrel.2023.11.058
   PubMed Web of Science ®Google Scholar
• Deng W, Shang H, Tong Y, et al. The application of nanoparticles-based ferroptosis, pyroptosis and autophagy in cancer immunotherapy. J Nanobiotechnology. 2024;22(1):97. doi:10.1186/s12951-024-02297-8
   PubMed Web of Science ®Google Scholar